Drug reference

everolimus

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Drug class

Oncology (TK Inhibitors)

Mechanism of action

Inhibitor of mammalian target of rapamycin (mTOR), a serine-threonine kinase; in several cancers and tuberous sclerosis complex, the mTOR pathway is dysregulated; everolimus binds to FKBP-12, an intracellular protein and thus inhibiting the mTOR kinase pathway

Common side effects

  • Asthenia
  • Constipation
  • Fatigue
  • Infection
  • Cough
  • Stomatitis
  • Diarrhea

Known interactions (28)

Related conditions

Frequently asked questions

What drug class is everolimus?

everolimus belongs to: Oncology.

How does everolimus work?

Inhibitor of mammalian target of rapamycin (mTOR), a serine-threonine kinase; in several cancers and tuberous sclerosis complex, the mTOR pathway is dysregulated; everolimus binds to FKBP-12, an intracellular protein and thus inhibiting the mTOR kinase pathway

What are the common side effects of everolimus?

Asthenia, Constipation, Fatigue, Infection, Cough, Stomatitis, Diarrhea

Which drugs interact with everolimus?

amiodarone, aprepitant, clarithromycin, dronedarone, ketoconazole, measles mumps and rubella vaccine, nilotinib, phenytoin, voriconazole, atorvastatin, chloramphenicol, clotrimazole, dasatinib, efavirenz, erythromycin

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug reference